Preprint Article Version 2 This version is not peer-reviewed

Self-Sampling for HPV Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs

Version 1 : Received: 30 November 2017 / Approved: 30 November 2017 / Online: 30 November 2017 (09:19:23 CET)
Version 2 : Received: 30 November 2017 / Approved: 1 December 2017 / Online: 1 December 2017 (07:19:13 CET)

A peer-reviewed article of this Preprint also exists.

Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, Bird SW, Bowers J, Smith A, Walton NA, Goddard AD, Almonacid DE, Zneimer S, Richman J and Apte ZS (2018) Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front. Public Health 6:77. doi: 10.3389/fpubh.2018.00077 Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, Bird SW, Bowers J, Smith A, Walton NA, Goddard AD, Almonacid DE, Zneimer S, Richman J and Apte ZS (2018) Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front. Public Health 6:77. doi: 10.3389/fpubh.2018.00077

Journal reference: Frontiers in Public Health 2018, 6, 77
DOI: 10.3389/fpubh.2018.00077

Abstract

In most industrialized countries, screening programs for cervical cancer have shifted from cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of screening for human papillomavirus (HPV), its main causative agent. For HPV testing, self-sampling instead of clinician-sampling has proven to be equally accurate, in particular for assays that use nucleic acid amplification techniques. In addition, HPV testing of self-collected samples in combination with a follow-up Pap smear in case of a positive result is more effective in detecting precancerous lesions than a Pap smear alone. Self-sampling for HPV testing has already been adopted by some countries, while others have started trials to evaluate its incorporation into national cervical cancer screening programs. Self-sampling may result in more individuals willing to participate in cervical cancer screening, because it removes many of the barriers that prevent women, especially those in low socioeconomic and minority populations, from participating in regular screening programs. Several studies have shown that the majority of women who have been underscreened but who tested HPV-positive in a self-obtained sample, will visit a clinic for follow-up diagnosis and management. Additionally, a self-collected sample can also be used for vaginal microbiome analysis, which can provide additional information about HPV infection persistence as well as vaginal health in general.

Subject Areas

human papillomavirus; HPV; cervical cancer; cancer screening; self-sampling; vaginal microbiome

Readers' Comments and Ratings (1)

Comment 1
Received: 18 May 2018
Commenter: Elisabeth Bik
Commenter's Conflict of Interests: I am one of the authors of the paper. I am a salaried employee of uBiome, Inc, San Francisco, CA.
Comment: Since its publication here on Preprints.org, this manuscript has been peer-reviewed and published in Frontiers in Public Health.
Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, Bird SW, Bowers J, Smith A, Walton NA, Goddard AD, Almonacid DE, Zneimer S, Richman J, Apte ZS
Front Public Health. 2018 Apr 09; 6
DOI: 10.3389/fpubh.2018.00077, PMCID: PMC5900042
+ Respond to this comment
Leave a public comment
Send a private comment to the author(s)
Rate this article
Views 0
Downloads 0
Comments 1
Metrics 0
Leave a public comment

×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.